{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:44:54Z","timestamp":1768074294044,"version":"3.49.0"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"14","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Nowadays, the emergence of methicillin-resistant Staphylococcus aureus (MRSA) and\nvancomycin-resistant S. aureus (VRSA) strains has dramatically restricted the treatment options against this\nmicroorganism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>In this study, we aimed to discover new drug targets and inhibitors against S. aureus.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This study consists of two major sections. In the upstream evaluation, after a comprehensive coreproteome\nanalysis, essential cytoplasmic proteins with no similarity to the human proteome were selected. Then the\nS. aureus metabolome-specific proteins were selected, and novel drug targets were identified using the DrugBank\ndatabase. In the downstream analysis, a structure-based virtual screening approach was performed to reveal potential\nhit compounds against adenine N1 (m1A22)-tRNA methyltransferase (TrmK) using the StreptomeDB library\nand AutoDock Vina software. The compounds with a binding affinity &gt; -9 kcal\/mol were analyzed based on ADMET\nproperties. Finally, the hit compounds were selected based on Lipinski\u2019s rule of five (RO5).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Three proteins, including glycine glycosyltransferase (FemA), TrmK, and heptaprenyl pyrophosphate\nsynthase subunit A (HepS1), were selected as feasible and promising drug targets based on PDB file availability\nand their essential role in the survival of the S. aureus. Finally, seven hit compounds, including Nocardioazine_\nA, Geninthiocin_D, Citreamicin_delta, Quinaldopeptin, Rachelmycin, Di-AFN_A1 and Naphthomycin_\nK were introduced against the binding cavity of TrmK, as a feasible drug target.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results of this study provided three feasible drug targets against S. aureus. In the following,\nseven hit compounds were introduced as potential inhibitors of TrmK, and Geninthiocin_D was identified as\nthe most desirable agent. However, in vivo and in vitro investigations are needed to confirm the inhibitory effect\nof these agents on S. aureus.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666230428105643","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:27:29Z","timestamp":1683095249000},"page":"1135-1147","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Introduction of Novel Drug Targets against Staphylococcus aureus and Proposing\nPutative Inhibitors against Adenine N1 (m1A22)-tRNA Methyltransferase (TrmK)\nusing Computer-aided Drug Discovery"],"prefix":"10.2174","volume":"29","author":[{"given":"Masoumeh","family":"Beig","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahereh","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Nanotechnology, New Technologies Research\nGroup, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narjes Noori","family":"Goodarzi","sequence":"additional","affiliation":[{"name":"Department of Pathobiology, School of Public Health, Tehran University of Medical\nSciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Fereshteh","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"Habibi","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Badmasti","sequence":"additional","affiliation":[{"name":"Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran"},{"name":"Microbiology Research Center\n(MRC), Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/IDR.S272733","volume":"13","author":"Algammal A.M.","year":"2020","unstructured":"Algammal A.M.; Hetta H.F.; Elkelish A.; Methicillin-Resistant Staphylococcus aureus (MRSA): One health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact. Infect Drug Resist 2020,13,3255-3265","journal-title":"Infect Drug Resist"},{"key":"ref=2","first-page":"176","volume":"1","author":"Ghassemi M.R.","year":"2020","unstructured":"Ghassemi M.R.; Doust R.H.; Haghight S.; Akhgari M.; Nazparvar B.; Evaluation of the toxic shock syndrome gene (TSSTI) of Staphylococcus aureus in deceased neonates of Tehran forensic medicine organization from October 2017 to October 2018. Arch Pharm Pract 2020,1,176","journal-title":"Arch Pharm Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"Lee A.S.","year":"2018","unstructured":"Lee A.S.; de Lencastre H.; Garau J.; Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 2018,4(1),18033","journal-title":"Nat Rev Dis Primers"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3345\/cep.2020.00255","volume":"64","author":"Sarrafzadeh F.","year":"2021","unstructured":"Sarrafzadeh F.; Sohrevardi S.M.; Abousaidi H.; Mirzaei H.; Prevalence of methicillin-resistant Staphylococcus aureus in Iranian children: A systematic review and meta-analysis. Clin Experiment Pediat 2021,64(8),415-421","journal-title":"Clin Experiment Pediat"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s40064-016-2277-3","volume":"5","author":"Ullah A.","year":"2016","unstructured":"Ullah A.; Qasim M.; Rahman H.; High frequency of methicillin-resistant Staphylococcus aureus in Peshawar Region of Pakistan. Springerplus 2016,5(1),600","journal-title":"Springerplus"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13059-017-1252-9","volume":"18","author":"Harkins C.P.","year":"2017","unstructured":"Harkins C.P.; Pichon B.; Doumith M.; Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol 2017,18(1),130","journal-title":"Genome Biol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"035001","DOI":"10.1088\/1748-605X\/abc7f2","volume":"16","author":"Zafari M.","year":"2021","unstructured":"Zafari M.; Adibi M.; Chiani M.; Effects of cefazolin-containing niosome nanoparticles against methicillin-resistant Staphylococcus aureus biofilm formed on chronic wounds. Biomed Mater 2021,16(3),035001","journal-title":"Biomed Mater"},{"key":"ref=8","year":"2019","unstructured":"Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC. CDCAvailable from: 2019"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11908-019-0695-4","volume":"21","author":"Sharma R.","year":"2019","unstructured":"Sharma R.; Hammerschlag M.R.; Treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in children: A reappraisal of vancomycin. Curr Infect Dis Rep 2019,21(10),37","journal-title":"Curr Infect Dis Rep"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","volume":"21","author":"Cong Y.","year":"2020","unstructured":"Cong Y.; Yang S.; Rao X.; Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features. J Adv Res 2020,21,169-176","journal-title":"J Adv Res"},{"key":"ref=11","first-page":"269","volume":"90","author":"McGuinness W.A.","year":"2017","unstructured":"McGuinness W.A.; Malachowa N.; DeLeo F.R.; Focus: infectious diseases: Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med 2017,90(2),269-281","journal-title":"Yale J Biol Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"104851","DOI":"10.1016\/j.compbiomed.2021.104851","volume":"137","author":"Shaker B.","year":"2021","unstructured":"Shaker B.; Ahmad S.; Lee J.; Jung C.; Na D.; In silico methods and tools for drug discovery. Comput Biol Med 2021,137,104851","journal-title":"Comput Biol Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","volume":"21","author":"Boike L.","year":"2022","unstructured":"Boike L.; Henning N.J.; Nomura D.K.; Advances in covalent drug discovery. Nat Rev Drug Discov 2022,21(12),881-898","journal-title":"Nat Rev Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.2147\/DDDT.S182444","volume":"12","author":"Atatreh N.","year":"2018","unstructured":"Atatreh N.; Ghattas M.A.; Bardaweel S.K.; Al Rawashdeh S.; Al Sorkhy M.; Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening. Drug Des Devel Ther 2018,12,3741-3752","journal-title":"Drug Des Devel Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-4939-9624-7_3","volume":"2025","author":"Kraft E.","year":"2019","unstructured":"Kraft E.; Franke Y.; Heeringa K.; Shriver S.; Zilberleyb I.; Kugel C.; Semiautomated small-scale purification method for high-throughput expression analysis of recombinant proteins. Methods Mol Biol 2019,2025,51-68","journal-title":"Methods Mol Biol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"100319","DOI":"10.1016\/j.jics.2021.100319","volume":"99","author":"Fereshteh S.","year":"2022","unstructured":"Fereshteh S.; Kalhor H.; Sepehr A.; Rational design of inhibitors against LpxA protein of Acinetobacter baumannii using a virtual screening method. J Indian Chem Soc 2022,99(2),100319","journal-title":"J Indian Chem Soc"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12539-019-00327-w","volume":"11","author":"Li J.","year":"2019","unstructured":"Li J.; Fu A.; Zhang L.; An overview of scoring functions used for protein-ligand interactions in molecular docking. Interdiscip Sci 2019,11(2),320-328","journal-title":"Interdiscip Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/nar\/28.1.15","volume":"28","author":"Benson D.A.","year":"2000","unstructured":"Benson D.A.; Karsch-Mizrachi I.; Lipman D.J.; Ostell J.; Rapp B.A.; Wheeler D.L.; GenBank. Nucleic Acids Res 2000,28(1),15-18","journal-title":"Nucleic Acids Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"24373","DOI":"10.1038\/srep24373","volume":"6","author":"Chaudhari N.M.","year":"2016","unstructured":"Chaudhari N.M.; Gupta V.K.; Dutta C.; BPGA- an ultra-fast pan-genome analysis pipeline. Sci Rep 2016,6(1),24373","journal-title":"Sci Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","volume":"26","author":"Yu N.Y.","year":"2010","unstructured":"Yu N.Y.; Wagner J.R.; Laird M.R.; PSORTb 3.0: Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 2010,26(13),1608-1615","journal-title":"Bioinformatics"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"271D","DOI":"10.1093\/nar\/gkh024","volume":"32","author":"Zhang R.","year":"2004","unstructured":"Zhang R.; Ou H.Y.; Zhang C.T.; DEG: a database of essential genes. Nucleic Acids Res 2004,32(90001 Pt 1),271D-2712","journal-title":"Nucleic Acids Res"},{"key":"ref=22","first-page":"177","author":"Bhagwat M.","year":"2007","unstructured":"Bhagwat M.; Aravind L.;  Psi-blast tutorial Comparative genomics 2007,177-186","journal-title":"Psi-blast tutorial Comparative genomics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"W182-5","DOI":"10.1093\/nar\/gkm321","volume":"35","author":"Moriya Y.","year":"2007","unstructured":"Moriya Y.; Itoh M.; Okuda S.; Yoshizawa A.C.; Kanehisa M.; KAAS: an automatic genome annotation and pathway reconstruction server. Nucleic Acids Res 2007,35(Suppl. 2),W182-5","journal-title":"Nucleic Acids Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.20801","volume":"30","author":"Brandon M.C.","year":"2009","unstructured":"Brandon M.C.; Ruiz-Pesini E.; Mishmar D.; MITOMASTER: a bioinformatics tool for the analysis of mitochondrial DNA sequences. Hum Mutat 2009,30(1),1-6","journal-title":"Hum Mutat"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"Wishart D.S.","year":"2018","unstructured":"Wishart D.S.; Feunang Y.D.; Guo A.C.; DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 2018,46(D1),D1074-D1082","journal-title":"Nucleic Acids Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1107\/S0907444998009378","volume":"54","author":"Sussman J.L.","year":"1998","unstructured":"Sussman J.L.; Lin D.; Jiang J.; Protein Data Bank (PDB): database of three-dimensional structural information of biological macromolecules. Acta Crystallogr D Biol Crystallogr 1998,54(6),1078-1084","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12010-022-04116-y","volume":"195","author":"Sabzi S.","year":"2022","unstructured":"Sabzi S.; Shahbazi S.; Noori Goodarzi N.; Haririzadeh Jouriani F.; Habibi M.; Bolourchi N.; Genome-wide subtraction analysis and reverse vaccinology to detect novel drug targets and potential vaccine candidates against Ehrlichia chaffeensis. Appl Biochem Biotechnol 2022,195(1),107-124","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/07391102.2019.1588784","volume":"38","author":"Kalhor H.","year":"2020","unstructured":"Kalhor H.; Sadeghi S.; Marashiyan M.; Identification of new DNA gyrase inhibitors based on bioactive compounds from streptomyces: Structure-based virtual screening and molecular dynamics simulations approaches. J Biomol Struct Dyn 2020,38(3),791-806","journal-title":"J Biomol Struct Dyn"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"Xiong G.","year":"2021","unstructured":"Xiong G.; Wu Z.; Yi J.; ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res 2021,49(W1),W5-W14","journal-title":"Nucleic Acids Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","volume":"12","author":"Ganesan A.","year":"2008","unstructured":"Ganesan A.; The impact of natural products upon modern drug discovery. Curr Opin Chem Biol 2008,12(3),306-317","journal-title":"Curr Opin Chem Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/wcms.1298","volume":"7","author":"Yuan S.","year":"2017","unstructured":"Yuan S.; Chan H.C.S.; Hu Z.; Using PyMOL as a platform for computational drug design. Wiley Interdiscip Rev Comput Mol Sci 2017,7(2),e1298","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"key":"ref=32","author":"Studio D.","year":"2008","unstructured":"Studio D.; Discovery studio. Accelrys Available from: .2008","journal-title":"Accelrys"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.jbc.2022.102040","volume":"298","author":"Sweeney P.","year":"2022","unstructured":"Sweeney P.; Galliford A.; Kumar A.; Raju D.; Krishna N.B.; Sutherland E.; Structure, dynamics, and molecular inhibition of the Staphylococcus aureus m1A22-tRNA methyltransferase TrmK. J Biol Chem 2022,298(6),102040","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","volume":"12","author":"Cheung G.Y.C.","year":"2021","unstructured":"Cheung G.Y.C.; Bae J.S.; Otto M.; Pathogenicity and virulence of Staphylococcus aureus. Virulence 2021,12(1),547-569","journal-title":"Virulence"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/B978-0-12-816125-8.00002-X","author":"Prieto-Mart&#xED;nez F.D.","year":"2019","unstructured":"Prieto-Mart&#xED;nez F.D.; L&#xF3;pez-L&#xF3;pez E.; Ju&#xE1;rez-Mercado K.E.; Medina-Franco J.L.; Chapter 2 - Computational Drug Design Methods-Current and Future Perspectives. In: In silico drug design repurposing techniques and methodologies 2019,19-44","journal-title":"In silico drug design repurposing techniques and methodologies"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"D509","DOI":"10.1093\/nar\/gkv1319","volume":"44","author":"Klementz D.","year":"2016","unstructured":"Klementz D.; D&#xF6;ring K.; Lucas X.; StreptomeDB 2.0-an extended resource of natural products produced by streptomycetes. Nucleic Acids Res 2016,44(D1),D509-D514","journal-title":"Nucleic Acids Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"D1130","DOI":"10.1093\/nar\/gks1253","volume":"41","author":"Lucas X.","year":"2013","unstructured":"Lucas X.; Senger C.; Erxleben A.; StreptomeDB: a resource for natural compounds isolated from Streptomyces species. Nucleic Acids Res 2013,41(D1),D1130-D1136","journal-title":"Nucleic Acids Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"Hughes J.P.","year":"2011","unstructured":"Hughes J.P.; Rees S.; Kalindjian S.B.; Philpott K.L.; Principles of early drug discovery. Br J Pharmacol 2011,162(6),1239-1249","journal-title":"Br J Pharmacol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.2174\/1568026618666181025092546","volume":"18","author":"Giuliodori A.M.","year":"2019","unstructured":"Giuliodori A.M.; Spurio R.; Mil&#xF3;n P.; Fabbretti A.; Antibiotics targeting the 30S ribosomal subunit: A lesson from nature to find and develop new drugs. Curr Top Med Chem 2019,18(24),2080-2096","journal-title":"Curr Top Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/jac\/dkh130","volume":"53","author":"Athamna A.","year":"2004","unstructured":"Athamna A.; Athamna M.; Medlej B.; Bast D.J.; Rubinstein E.; In vitro post-antibiotic effect of fluoroquinolones, macrolides, -lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin\/dalfopristin and rifampicin on Bacillus anthracis. J Antimicrob Chemother 2004,53(4),609-615","journal-title":"J Antimicrob Chemother"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/med.21780","volume":"41","author":"Zhang L.","year":"2021","unstructured":"Zhang L.; He J.; Bai L.; Ruan S.; Yang T.; Luo Y.; Ribosome targeting antibacterial agents: Advances, challenges, and opportunities. Med Res Rev 2021,41(4),1855-1889","journal-title":"Med Res Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/S0969-2126(02)00807-9","volume":"10","author":"Benson T.E.","year":"2002","unstructured":"Benson T.E.; Prince D.B.; Mutchler V.T.; X-ray crystal structure of Staphylococcus aureus FemA. Structure 2002,10(8),1107-1115","journal-title":"Structure"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1128\/jb.173.11.3507-3513.1991","volume":"173","author":"Maidhof H.","year":"1991","unstructured":"Maidhof H.; Reinicke B.; Bl&#xFC;mel P.; Berger-B&#xE4;chi B.; Labischinski H.; femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. J Bacteriol 1991,173(11),3507-3513","journal-title":"J Bacteriol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/147323000803600306","volume":"36","author":"Li X.","year":"2008","unstructured":"Li X.; Xiong Y.; Fan X.; A study of the regulating gene of femA from methicillin-resistant Staphylococcus aureus clinical isolates. J Int Med Res 2008,36(3),420-433","journal-title":"J Int Med Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1021\/ol200904v","volume":"13","author":"Raju R.","year":"2011","unstructured":"Raju R.; Piggott A.M.; Huang X.C.; Capon R.J.; Nocardioazines: a novel bridged diketopiperazine scaffold from a marine-derived bacterium inhibits P-glycoprotein. Org Lett 2011,13(10),2770-2773","journal-title":"Org Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/cmdc.201600311","volume":"11","author":"Desai J.","year":"2016","unstructured":"Desai J.; Liu Y.L.; Wei H.; Structure, function, and inhibition of Staphylococcus aureus heptaprenyl diphosphate synthase. Chem Med Chem 2016,11(17),1915-1923","journal-title":"Chem Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1093\/nar\/gkn169","volume":"36","author":"Roovers M.","year":"2008","unstructured":"Roovers M.; Kaminska K.H.; Tkaczuk K.L.; Gigot D.; Droogmans L.; Bujnicki J.M.; The YqfN protein of Bacillus subtilis is the tRNA: m 1 A22 methyltransferase (TrmK). Nucleic Acids Res 2008,36(10),3252-3262","journal-title":"Nucleic Acids Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/B978-0-12-816911-7.00006-2","author":"Am&#xE9;zqueta S.","year":"2020","unstructured":"Am&#xE9;zqueta S.; Subirats X.; Fuguet E.; Ros&#xE9;s M.; R&#xE0;fols C.; Chapter 6 - Octanol-Water Partition Constant. In: Liquid-phase extraction handbooks in separation science Available from: 2020,183-208","journal-title":"Liquid-phase extraction handbooks in separation science"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1021\/np800503z","volume":"71","author":"Hopp D.C.","year":"2008","unstructured":"Hopp D.C.; Milanowski D.J.; Rhea J.; Citreamicins with potent gram-positive activity. J Nat Prod 2008,71(12),2032-2035","journal-title":"J Nat Prod"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7164\/antibiotics.43.796","volume":"43","author":"Toda S.","year":"1990","unstructured":"Toda S.; Sugawara K.; Nlshiyama Y.; Quinaldopeptin, a novel antibiotic of the quinomycin family. J Antibiot 1990,43(7),796-808","journal-title":"J Antibiot"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0009-2797(92)90012-A","volume":"82","author":"Krueger W.C.","year":"1992","unstructured":"Krueger W.C.; Prairie M.D.; Calf thymus DNA binding\/bonding properties of CC-1065 and analogs as related to their biological activities and toxicities. Chem Biol Interact 1992,82(1),31-46","journal-title":"Chem Biol Interact"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230428105643","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216333\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230428105643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T16:31:59Z","timestamp":1691425919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216333\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666230428105643","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}